Communication
ChemComm
of 2-thiopheneacetyl-ACP with both enzymes is also the lowest to inhibit both ketosynthase and ketoreductase is particularly
among all substrates in our library suggesting a tightly bound appealing to develop potent fatty acid synthase inhibitors, develop
[enzyme–substrate] complex for this substrate (Tables S1 and mechanistic probes that could arrest polyketide synthesis at specific
S2, ESI†). Although commonly found in proteins, hydrogen steps and discover novel antivirulent compounds that inactivate
bonding interactions with sulfur are proposed to be weaker 3-oxoacyl-homoserine lactone synthases from pathogenic bacteria.
compared to oxygen and the increased aromatic character of
Financial support for this project came from Boise State
thiophene should further diminish the potential of sulfur atom University start-up funds (RN), NIH 1R15GM117323-01 (RN),
to accept a hydrogen bond from a donor residue in the active NIH INBRE grants P20 RR016454 and P20 GM103408. Noah
1
1
site. Nevertheless, sulfur also participates in ‘‘sigma hole’’ Collingwood was supported by the American Chemical Society
1
2
interactions with electronegative atoms such as N, O etc.
Project SEED fellowship.
Quantum mechanical calculations reveal that the magnitude
of interaction energies at the sigma hole could match typical
hydrogen bond energies (22 to 30 kJ mol ). In addition, the
À1 13
Conflicts of interest
size of two sigma holes on the divalent sulfur are larger on
aromatic rings such as thiophene. It appears these additional
sigma hole interactions for sulfur could have likely contributed
There are no conflicts of interests to declare.
1
4
Notes and references
1 (a) B. A. Pfeifer, S. J. Admiraal, H. Gramajo., D. E. Cane and C. Khosla,
Science, 2001, 291, 1790; (b) J. E. Cronan and J. Thomas, Methods
Enzymol., 2009, 459, 395; (c) A. T. Keatinge-Clay, Angew. Chem., Int. Ed.,
2017, 56, 4658.
to the low K
addition, we observe that the apparent K
m
of 2-thiopheneacetyl-ACP with EsaI and YspI. In
SAM
m
is about 3-fold
lower when the fixed substrate is 2-thiopheneacetyl-ACP relative
to the most active acyl-ACP substrate with both EsaI and YspI
2
(a) J.-A. Chuck, M. McPherson, H. Huang, J. R. Jacobsen, C. Khosla
and D. E. Cane, Chem. Biol., 1997, 4, 757; (b) A. K. Brown, R. C. Taylor,
A. Bhatt, K. Futterer and G. S. Besra, PLoS One, 2009, 4, e6306;
(c) G. R. Bommineni, K. Kapilashrami, J. E. Cummings, Y. Lu,
S. E. Knudson, C. Gu, S. G. Walker, R. A. Slayden and P. J. Tonge,
J. Med. Chem., 2016, 59, 5377; (d) M. A. Hardwicke, et al., Nat. Chem.
Biol., 2014, 10, 774; (e) J. Wang, R. Hudson and H. O. Sintim, Future
Med. Chem., 2012, 4, 1113.
(
Table S3, ESI†). Interestingly, the kcat is also 4–5 fold lower
when the acyl-substrate is 2-thiopheneacetyl-ACP compared to
-furanacetyl-ACP for EsaI or 2-benzofuranacetyl-ACP for YspI
Tables S1–S3, ESI†). The above observations suggest that the
2
(
[
EÁ2-thiopheneacetyl-ACPÁSAM] ternary complexes in both enzymes
are perhaps in a non-optimal mode for chemistry and product
release steps in AHL synthesis. The ability of the thio-analog to
bind tighter, albeit in a less-productive mode for substrate
turnover should inform future design of inhibitors for this
class of enzymes.
3
4
(a) V. Agarwal, S. Diethelm, L. Ray, N. Garg, T. Awakawa, P. C. Dorrestein
and B. S. Moore, Org. Lett., 2015, 17, 4452; (b) D. T. Wagner, D. C. Stevens,
M. R. Mehaffey, H. R. Manion, R. E. Taylor, J. S. Brodbelt and
A. T. Keatinge-Clay, Chem. Commun., 2016, 52, 8822.
(a) W. T. Watson, T. D. Minogue, D. L. Val, S. B. von Bodman and
M. E. A. Churchill, Mol. Cell, 2002, 9, 685; (b) T. A. Gould, H. P. Schweizer
and M. E. A. Churchill, Mol. Microbiol., 2004, 53, 1135; (c) J. P. Kirwan.,
T. A. Gould, H. P. Schweizer, S. W. Bearden, R. C. Murphy and
M. E. A. Churchill, J. Bacteriol., 2006, 188, 784.
The small library of b-ketoacyl-ACP mimics described in this
work was designed to evaluate key structural features essential
for substrate activity with b-ketoacyl-ACP utilizing AHL synthase
enzymes such as EsaI and YspI. In this study, we have uncovered
5
6
L. Nyulaszi, P. Varnai and T. Veszpremi, J. Mol. Struct., 1995, 358, 55.
F. G. Bordwell, Acc. Chem. Res., 1988, 21, 456.
2
-furanacetyl-ACP and 2-benzofuranacetyl-ACP, respectively, as
7 (a) C. M. Waters and B. L. Bassler, Annu. Rev. Cell Dev. Biol., 2005, 21, 319;
b) M. E. Pomianek and M. F. Semmelhack, ACS Chem. Biol., 2007, 2, 293;
c) Q. H. Christensen, R. M. Brecht, D. Dudekula, E. P. Greenberg and
(
(
the most active b-ketoacyl-ACP mimic for 3-oxohexanoyl-ACP
utilizing EsaI and 3-oxooctanoyl-ACP utilizing YspI enzymes.
The bar diagram in Fig. 3 reveals that the catalytic efficiencies of
R. Nagarajan, PLoS One, 2014, 9, e112464; (d) S.-H. Dong, N. D. Frane,
Q. H. Christensen, E. P. Greenberg, R. Nagarajan and S. K. Nair, Proc.
Natl. Acad. Sci. U. S. A., 2017, 114, 9092; (e) W. Fast and P. A. Tipton,
Trends Biochem. Sci., 2012, 37, 7.
Q. H. Christensen, T. L. Grove, S. J. Booker and E. P. Greenberg,
Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 13815.
2
-furanacetyl-ACP (EsaI) and 2-benzofuranacetyl-ACP (YspI) are
at least similar or in some cases, even higher than the catalytic
efficiencies of native substrates with several well-characterized
AHL synthases. This data seems to indicate that the activity of
8
9
9 D. Shin, N. D. Frane, R. M. Brecht, J. Keeler and R. Nagarajan,
ChemBioChem, 2015, 16, 2651.
2
-furanacetyl-ACP with EsaI and 2-benzofuranacetyl-ACP with
10 T. A. Gould, J. Herman, J. Krank, R. C. Murphy and M. E. A. Churchill,
J. Bacteriol., 2006, 188, 773.
YspI should closely mirror the activity of 3-oxoacyl-ACPs (if they
can be successfully isolated) with these enzymes.
The flexibility to load a wide range of carrier proteins on to
the beta-ketoacyl-chain mimics described in this study should
open new avenues for mechanistic investigation of beta-ketoacyl-
ACP utilizing enzymes in therapeutically important biosynthetic
1
1 (a) L. A. H. van Bergen, M. Alonso, A. Pallo, L. Nilsson, F. D. Proft
and J. Messens, Sci. Rep., 2016, 6, 30369; (b) J. A. Platts, S. T. Howard
and R. F. Bracke, J. Am. Chem. Soc., 1996, 118, 2726; (c) K. E. Horner
and P. B. Karadakov, J. Org. Chem., 2013, 78, 8037.
1
2 (a) P. Guo, A. Paul, A. Kumar, A. A. Farahat, D. Kumar, S. Wang,
D. W. Boykin and W. D. Wilson, Chemistry, 2016, 22, 15404;
(
b) S. Sirimulla, J. B. Bailey, R. Vegesna and M. Narayan, J. Chem.
2
pathways. While b-ketoacyl-ACP mimics could be explored as
Inf. Model., 2013, 53, 2781.
1
3 M. R. Koebel, A. Cooper, G. Schmadeke, S. Jeon, M. Narayan and
S. Sirimulla, J. Chem. Inf. Model., 2016, 56, 2298.
4 J. S. Murray, P. Lane and P. Politzer, Int. J. Quantum Chem., 2008,
108, 2770.
ketosynthase product inhibitors, the inert, ring substrate analogs
such as 2-furanacetyl-ACP could be used to develop competitive
inhibitors for ketoreductase. The potential of b-ketoacyl-ACP mimics
1
Chem. Commun.
This journal is ©The Royal Society of Chemistry 2018